Nassim Usman
President & CEO at Gyre Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 3 years
- Director since
- 2023
3 years of board service in total across 1 board, counting each seat separately. Longest: Gyre Therapeutics Inc., 3 years.
Gyre Therapeutics Inc.
Director · President & CEO
Chief executive roles
Gyre Therapeutics Inc.
· President & CEO
Until October 2023
· Former
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Jun 28, 2024 | Gyre Therapeutics Inc. | Option exercise | +3,452 | $6.93 | $23,922 |
| Jun 28, 2024 | Gyre Therapeutics Inc. | Open-market sale | −3,452 | $12.00 | $41,424 |
| May 1, 2024 | Gyre Therapeutics Inc. | Option exercise | +20,000 | $6.93 | $138,600 |
| May 1, 2024 | Gyre Therapeutics Inc. | Open-market sale | −14,900 | $13.86 | $206,514 |
| May 1, 2024 | Gyre Therapeutics Inc. | Open-market sale | −5,000 | $14.90 | $74,500 |
| May 1, 2024 | Gyre Therapeutics Inc. | Open-market sale | −100 | $15.63 | $1,563 |
| Apr 1, 2024 | Gyre Therapeutics Inc. | Option exercise | +20,000 | $6.93 | $138,600 |
| Apr 1, 2024 | Gyre Therapeutics Inc. | Open-market sale | −20,000 | $16.15 | $323,000 |
| Mar 15, 2024 | Gyre Therapeutics Inc. | Option exercise | +20,000 | $6.93 | $138,600 |
| Mar 15, 2024 | Gyre Therapeutics Inc. | Open-market sale | −20,000 | $17.26 | $345,200 |
| Aug 31, 2023 | Gyre Therapeutics Inc. | Sold back to the company | −25 | — | — |
| Aug 31, 2023 | Gyre Therapeutics Inc. | Sold back to the company | −8 | — | — |
| Aug 31, 2023 | Gyre Therapeutics Inc. | Sold back to the company | −1 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.